FiercePharma· @FiercePharma · X·· 6 天前精选AI 评分58
AI 导读
Summit Therapeutics已与首席商务官及其他负责制定ivonescimab上市计划的商业化负责人低调分道扬镳。报道指出,该公司商业化与市场领导层出现空缺,同时ivonescimab的PDUFA决定临近。
推荐理由
在ivonescimab的PDUFA决定临近之际,其商业化团队负责人离职,读者可据此关注产品上市准备与审评节奏的衔接。
正文
Summit Therapeutics quietly parted ways with its chief commercial officer and other commercial leaders responsible for building the launch plan of ivonescimab. https://www.fiercepharma.com/pharma/summits-commercial-and-market-leadership-gaps-pdufa-decision-looms
来源:FiercePharma · x.com